NCT00723320

Brief Summary

The purpose of this study is to determine whether atorvastatin, aggressive lifestyle intervention, and their interaction are effective in delaying the progress of pre-clinical atherosclerosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 28, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

August 25, 2008

Status Verified

July 1, 2008

Enrollment Period

2.8 years

First QC Date

July 21, 2008

Last Update Submit

August 22, 2008

Conditions

Keywords

AtherosclerosisAtorvastatinTherapeutic lifestyle changeCIMTABIPWV

Outcome Measures

Primary Outcomes (1)

  • The progress of CIMT

    2 years

Secondary Outcomes (3)

  • The progress of ABI

    2 years

  • The progress of PWV

    2 years

  • Occurrence of atherosclerotic disease

    2 years

Study Arms (4)

P+N

NO INTERVENTION

placebo without lifestyle intervention

D+N

EXPERIMENTAL

Atorvastatin 10mg/d

Drug: Atorvastatin

P+A

EXPERIMENTAL

lifestyle intervention without Atorvastatin

Behavioral: Aggressive lifestyle intervention

D+A

EXPERIMENTAL

lifestyle intervention and Atorvastatin 10mg/d

Drug: AtorvastatinBehavioral: Aggressive lifestyle intervention

Interventions

atorvastatin 10mg/d

D+AD+N

aggressive lifestyle intervention

D+AP+A

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CIMT is not less than 0.9 mm
  • without Clinical diagnosis of atherosclerotic disease
  • without Diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

RECRUITING

MeSH Terms

Conditions

Atherosclerosis

Interventions

Atorvastatin

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

PyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeptanoic AcidsFatty AcidsLipids

Study Officials

  • Jianping Li

    Peking University First Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jianping Li

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

July 21, 2008

First Posted

July 28, 2008

Study Start

February 1, 2008

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

August 25, 2008

Record last verified: 2008-07

Locations